Sort
39,280 grants matching “leukemia”
Perinatal immune development and risk of childhood acute lymphoblastic leukemia
$445,030Joseph Leo Wiemels · University Of Southern California · R01 · FY2018 · CA
Multi-Spectral Parallel-Plate Diffuse Optical Breast Tomography
$445,027Arjun G. Yodh · University Of Pennsylvania · R01 · FY2011 · EB
Platinum Metal Complexes as DNA-Protein Cross-Linking Agents
$445,000Nicholas P Farrell · Virginia Commonwealth University · · FY2003 · MPS
Molecular mechanisms of splicing dependency in cohesin-mutant myelodysplasia
$445,000Zuzana Tothova · Dana-Farber Cancer Inst · R01 · FY2024 · HL
Molecular mechanisms of splicing dependency in cohesin-mutant myelodysplasia
$445,000Zuzana Tothova · Dana-Farber Cancer Inst · R01 · FY2025 · HL
Mechanisms of Impaired Granulopoiesis Due to CLPB Mutations
$445,000Julia Therese Warren · Children'S Hosp Of Philadelphia · R00 · FY2025 · HL
Human papillomavirus entry: late trafficking and establishment of infection
$444,993Katarzyna Zwolinska · Louisiana State Univ Hsc Shreveport · R01 · FY2025 · AI
TARGETING ROR1 WITH CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
$444,969Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Exploring the Impact of Base Deaminase Deregulation on Precancer Evolution
$444,952Catriona Helen Macleod Jamieson · University Of California, San Diego · R01 · FY2025 · CA
Endocrine Disruptors: Assessment of endocrine disruption activity, mechanism and
$444,890Subhrangsu S Mandal · University Of Texas Arlington · R15 · FY2010 · ES
Developmental Funds
$444,880Caryn Lerman · University Of Southern California · P30 · FY2022 · CA
Restoration of Tumor Suppression Activity in Malignant Melanoma
$444,787David Joseph Weber · University Of Maryland Baltimore · R01 · FY2014 · CA
Improving genetically engineered T cells for medulloblastomas
$444,775Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2025 · NS
Improving genetically engineered T cells for medulloblastomas
$444,775Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2022 · NS
Improving genetically engineered T cells for medulloblastomas
$444,775Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2023 · NS
Improving genetically engineered T cells for medulloblastomas
$444,775Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2021 · NS
Discovery of novel PCFT-targeted agents
$444,742Larry H. Matherly · Wayne State University · R01 · FY2014 · CA
Characterization of Lamprey B cells and Antibodies
$444,712Max D Cooper · Emory University · R01 · FY2021 · AI
Characterization of Lamprey B cells and Antibodies
$444,712Max D Cooper · Emory University · R01 · FY2019 · AI
Characterization of Lamprey B cells and Antibodies
$444,712Max D Cooper · Emory University · R01 · FY2020 · AI
Characterization of Lamprey B cells and Antibodies
$444,712Max D Cooper · Emory University · R01 · FY2022 · AI
Mechanisms/Transformation by TAL1/SCL in Thymic Neoplasm
$444,656Dana-Farber Cancer Institute · P01 · FY2005 · CA
The role and mechanism of FTO in leukemogenesis and drug response
$444,571Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA
Multi-Spectral Parallel-Plate Diffuse Optical Breast Tomography
$444,568Arjun G. Yodh · University Of Pennsylvania · R01 · FY2012 · EB
Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE
$444,555Aasthaa Bansal · University Of Washington · R37 · FY2021 · CA